Advanced Search

Pathology/Lab Coding Alert

CCI Edits:

87493 C. Difficile Test Catches More Restrictions Under CCI 17.3

Published on Tue Nov 08, 2011

Plus: Limit 86000 blood processing codes with HCPCS Level II 'P' codes.Already restricted by CPT® instruction and prior Correct Coding Initiative (CCI) edits, you'll find even more limitations for reporting amplified-probe Clostridium difficile testing, thanks to new edit pairs in the third quarter CCI update.CCI version 17.3, effective Oct. 1, offers 1,380 new edit pairs and 835 terminated bundles, according to an analysis by Frank Cohen, MPA, MBB, principal and senior analyst with The Frank Cohen Group, LLC. Let us help you peer through the numbers to learn the CCI changes that will impact your laboratory.'Complete' Amplified Probe Code Stands AloneEarlier CCI versions bundled 87493 (Clostridium difficile, toxin gene[s], amplified probe technique) with several molecular diagnostics codes in the range 83890-83913 (Molecular diagnostics ...).Now CCI 17.3 also lists 87493 as the column one code with the following six codes in that range:83891 -- Molecular diagnostics; isolation or extraction of highly purified [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Pathology/Lab Coding Alert

View All